Final results from a phase II trial of ZD1839 ("Iressa") for patients with advanced non-small-cell lung cancer (IDEAL 1)

@inproceedings{Fukuoka2002FinalRF,
  title={Final results from a phase II trial of ZD1839 ("Iressa") for patients with advanced non-small-cell lung cancer (IDEAL 1)},
  author={Masahiro Fukuoka},
  year={2002}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 47 CITATIONS

Clinical experience with gefitinib in Indian patients.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2008